Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK2 | O60674 | 8/20 | 0.44 |
| ▸ | JAK1 | P23458 | 8/20 | 0.44 |
| ▸ | TYK2 | P29597 | 8/20 | 0.44 |
| ▸ | JAK3 | P52333 | 8/20 | 0.44 |
| ▸ | PTGER4 | P35408 | 4/20 | 0.43 |
| ▸ | MCHR1 | Q99705 | 4/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | ITGB3 | P05106 | 3/20 | 0.39 |
| ▸ | ITGA2B | P08514 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9255102 | 0.92 | PTGER4 (0.47) | JAK2JAK1TYK2JAK3PTGER4 | |
| Hydrochloric Acid SCHEMBL9248958 | 0.91 | PTGER4 (0.46) | JAK2JAK1TYK2JAK3PTGER4 | |
| SCHEMBL9248699 | 0.90 | JAK2 (0.44) | JAK2JAK1TYK2JAK3PTGER4 | |
| SCHEMBL9255435 | 0.90 | PTGER4 (0.52) | JAK2JAK1TYK2JAK3PTGER4 | |
| SCHEMBL9248459 | 0.89 | ITGB3 (0.45) | JAK2JAK1TYK2JAK3PTGER4 | |
| SCHEMBL9247726 | 0.88 | JAK2 (0.43) | JAK2JAK1TYK2JAK3PTGER4 | |
| SCHEMBL9255982 | 0.87 | JAK2 (0.52) | JAK2JAK1TYK2JAK3PTGER4 | |
| SCHEMBL9248802 | 0.87 | PTGER4 (0.52) | JAK2JAK1TYK2JAK3PTGER4 | |
| SCHEMBL9248925 | 0.86 | PTGER4 (0.51) | JAK2JAK1TYK2JAK3PTGER4 | |
| SCHEMBL9257115 | 0.86 | JAK2 (0.60) | JAK2JAK1TYK2JAK3PTGER4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5434150-A | Anticoagulants, cardiovascular disorders | DR. KARL THOMAE GMBH (DE) | 1995-07-18 | — | — | US | claimed |
| EP-0531883-A1 | Condensed 5-membered ring heterocycles, process for their preparation and medicaments containing them | Dr. Karl Thomae GmbH (DE) | 1993-03-17 | — | — | EP | claimed |
| US-5434150-A | Anticoagulants, cardiovascular disorders | DR. KARL THOMAE GMBH (DE) | 1995-07-18 | — | — | US | disclosed |
| EP-0531883-A1 | Condensed 5-membered ring heterocycles, process for their preparation and medicaments containing them | Dr. Karl Thomae GmbH (DE) | 1993-03-17 | — | — | EP | disclosed |